Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
ML Saetersmoen, Q Hammer, B Valamehr… - Seminars in …, 2019 - Springer
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
ML Saetersmoen, Q Hammer… - Seminars in …, 2019 - pubmed.ncbi.nlm.nih.gov
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
ML Saetersmoen, Q Hammer… - Seminars in …, 2019 - search.ebscohost.com
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
ML Sætersmoen, Q Hammer, B Valamehr… - Seminars in …, 2018 - duo.uio.no
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
ML Saetersmoen, Q Hammer… - Seminars in …, 2019 - search.proquest.com
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
ML Saetersmoen, Q Hammer, B Valamehr… - Seminars in …, 2018 - europepmc.org
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
ML Saetersmoen, Q Hammer, B Valamehr… - Seminars in …, 2019 - escholarship.org
Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …